Earnings quality
Compare earnings and operating cash flow for earnings quality.
LG Chem, Ltd.
Ticker 051910 Β· π°π· Korea Β· Consolidated K-IFRS Β· amounts in won
Filed 2025-03-31 Β· Period end 2024-12-31
Takeaway
Worth trackingSales and operating profit both moved in a healthier direction.
operating margin is 61.9%.
Sales and operating profit moved together β keep watching margins and whether the trend persists next period.
ActionWorth tracking
OP margin61.9%
Equity ratioβ
Last priceβ
Trailing P/Eβ
Look at next
- Compare operating cash flow to reported profit across the last two years.
- Open English IR for management commentary on outlook and capital allocation.
- Overlay peers on Compare before judging relative momentum.
About the company
LG Chem, Ltd. is a Korea-listed company with consolidated financial statements filed on DART (Open DART).
Financial statements
Income statement
| Account | FY2023 (ended Dec 31, 2023) | FY2024 (ended Dec 31, 2024) |
|---|---|---|
| Revenue | β©676.9B | β©1.5T |
| Cost of sales* | -β©8.1T | -β©6.1T |
| Gross profit | β©8.8T | β©7.5T |
| Operating profit | β©2.5T | β©916.8B |
| Finance income | β©1.8T | β©2.1T |
| Finance costs | β©1.7T | β©2.7T |
| Income tax | β©432.5B | β©61.0B |
| Profit for the period | β©2.1T | β©515.0B |
| Profit to owners | β©2.1T | β©515.0B |
| Basic EPS | 17,086.00 | -8,826.00 |
Balance sheet
| Account | FY2023 (ended Dec 31, 2023) | FY2024 (ended Dec 31, 2024) |
|---|---|---|
| Cash & equivalents | β©9.1T | β©7.9T |
| Current assets | β©28.9T | β©27.8T |
| Non-current assets | β©48.6T | β©66.0T |
| Total assets | β | β |
| Current liabilities | β©18.4T | β©21.1T |
| Short-term borrowings | β | β |
| Non-current liabilities* | β | β |
| Total liabilities | β | β |
| Ownersβ equity | β©40.9T | β©48.0T |
| Total equity | β©40.9T | β©48.0T |
Cash flow statement
| Account | FY2023 (ended Dec 31, 2023) | FY2024 (ended Dec 31, 2024) |
|---|---|---|
| Operating cash flow | β©7.5T | β©7.0T |
| Investing cash flow | -β©13.2T | -β©13.7T |
| Financing cash flow | β©6.2T | β©4.8T |
| Net change in cash | β | β |
| Cash at end of period | β©9.1T | β©7.9T |
Five-year trends
Key metrics
| Metric | Trend | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|---|
| Operating profit | β©1.8T | β©5.0T | β©3.0T | β©2.5T | β©916.8B | |
| Profit to owners | β©682.4B | β©4.0T | β©2.2T | β©2.1T | β©515.0B | |
| Total assets | β©41.4T | β©51.1T | β©68.0T | β | β | |
| Cash & equivalents | β©3.3T | β©3.8T | β©8.5T | β©9.1T | β©7.9T | |
| Ownersβ equity | β©18.8T | β©23.2T | β©37.5T | β©40.9T | β©48.0T |
How we read these numbers
From the notes
No material one-offs extracted from this filing.
Constructive
Sales and operating profit both moved in a healthier direction.
On the income statement, revenue moved from β©676.9B to β©1.5T (β² +118.7%). Operating profit went from β©2.5T to β©916.8B (βΌ -63.8%).
Operating cash flow was β©7.0T (prior β©7.5T), with cash on the balance sheet at β©7.9T versus β©9.1T.
Liquidity & leverage
Watch short-term liabilities against the cash balance.
Capital buffer
Total equity moved from β©40.9T to β©48.0T.
Was this page helpful?
Source: DART 20250731000339
((μ£Ό)LGνν), period end 2024-12-31.